Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2018-12-14 AGM Information
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
2018年第三次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the "2018 Third Extraordinary General Meeting of Shareholders" of 普莱柯生物工程股份有限公司. It contains detailed meeting instructions, agenda, and multiple proposals to be voted on by shareholders, including amendments to the company charter, fundraising management system, and adjustments to investment projects. The content is focused on the organization, procedures, and resolutions of a shareholders' meeting rather than financial results, audit opinions, or management reports. It is not a full annual or interim report, nor an earnings release or call transcript. The document is clearly a set of meeting materials for a shareholders' meeting, which fits the definition of AGM Information (AGM-R). The document length is substantial (9879 characters), indicating it is the meeting materials themselves, not just an announcement of a meeting or report publication. Therefore, the correct classification is AGM Information (AGM-R).
2018-12-14 Chinese
关于召开2018年第三次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about convening the 2018 third extraordinary general meeting of shareholders, detailing the meeting date, voting methods, agenda items, and procedural instructions. It includes information about the proxy form and voting rights but does not contain any financial statements or results. The document is an announcement related to a shareholders' meeting rather than the meeting materials or results themselves. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2018-12-11 Chinese
第三届董事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board of directors meeting of 普莱柯生物工程股份有限公司. It details the meeting date, attendance, and voting results on several governance-related proposals, including amendments to the company charter and governance systems, and the calling of a shareholders meeting. The document does not contain financial statements or detailed financial data, nor is it a transcript or presentation. It is not an announcement of voting results from a shareholder meeting but rather a board meeting resolution announcement. The content aligns with Board/Management Information filings, which cover announcements of board decisions and management matters. The document length is short (903 characters), and it is not merely an announcement of a report publication but a substantive announcement of board resolutions. Therefore, the appropriate classification is MANG (Board/Management Information).
2018-12-11 Chinese
募集资金管理制度（2018年12月修订）
Capital/Financing Update Classification · 95% confidence The document is titled '募集资金管理制度' which translates to 'Fundraising Capital Management System'. It details the rules, procedures, and regulations for managing and using funds raised by the company through securities issuance. The content includes references to regulatory laws, responsibilities of the board, use of funds, storage, supervision, and reporting requirements related to fundraising capital. It is a detailed policy or management system document rather than a financial report, earnings release, or announcement. It does not contain financial statements or results, nor is it a brief announcement or presentation. It is a regulatory compliance and internal management document related to capital raising activities. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP), as it pertains to the management and use of capital raised by the company.
2018-12-11 Chinese
独立董事关于第三届董事会第十四次会议相关事项的独立意见
Board/Management Information Classification · 90% confidence The document is an independent opinion from the independent directors regarding an adjustment to the company's fundraising project implementation plan, referencing relevant laws and company regulations. It is a formal statement related to board matters and fundraising project adjustments, but it does not contain financial statements or detailed financial data. The document length is very short (379 characters), and it is a formal opinion rather than a report or announcement of voting results. It relates to board-level decisions and fundraising project adjustments, but since it is an independent opinion on a board meeting matter, it fits best under Board/Management Information (MANG).
2018-12-11 Chinese
信息披露事务管理制度（2018年12月修订）
Governance Information Classification · 95% confidence The document is titled '信息披露事务管理制度' which translates to 'Information Disclosure Management System'. It details the company's policies, principles, responsibilities, and procedures for information disclosure, including references to regulatory laws, stock exchange rules, and specific reporting requirements such as annual reports, interim reports, and disclosures of major events. It does not contain actual financial data or financial statements but rather outlines the governance and management framework for disclosures. The document is a governance-related internal policy document rather than a financial report or announcement. Therefore, it fits best under Governance Information (CGR). The document length is substantial and it is not a brief announcement or certification, so it is not RPA or RNS.
2018-12-11 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.